Device Trial Radar · NCT03454334
Visual Performance of Four Types of Multifocal Intraocular Lenses
Last checked: Nov 20, 2026Latest source record: Apr 18, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
141
Actual
Start
Aug 11, 2013
Primary completion
Nov 18, 2019
Study completion Jan 14, 2020
Sponsor
- Lead sponsor
- Shahid Beheshti UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 5, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 40 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This investigation assessed the visual performance of presbyopia and cataract patients after bilateral implantation of 4 distinct sorts of multifocal IOLs: At lisa tri, PanOptix, ReSTOR, and Symfony. The clinical results demonstrated here were excellent for four groups, however, there were also differences in group ReSTOR, UCVA and BCVA for the intermediate and near of the other groups showed less vision also symphony group for far distance demonstrated less vision than other groups, which may be related to their design.Multifocal IOLs demonstrated very good technology and unquestionably have a place in refractive surgery, whether for clear lens extraction or cataracts.Patients can expect excellent outcomes and surgeons can expect patients to be very satisfied with surgical outcomes. Four groups multifocal lenses provided excellent distance, intermediate and near vision, but several measures indicated that the PanOptix and at lisa tri lens provided better vision in all distances. Spectacle independence was significantly higher with four groups. Multifocal IOL design might play a role in the postsurgical outcome, because better results were obtained with diffractive lenses. Although there were differences in the results of these four lenses in the study, all of the results were acceptable.
Conditions
- Cataract
Interventions
multifocal intraocular lens IOLsDevice
clinical outcome of different multifocal intraocular lenses (IOLs) in patients with presbyopia or cataracts
Primary outcomes
What the sponsor says the trial is designed to measure.
- Contrast sensitivityTime frame: 4 years
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.